文献速递淋巴瘤

靶向条件培养基依赖性与FLT-3在慢性淋巴细胞白血病中的作用

Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia.
PubMed 文献 · Blood Adv · 2023-01-01

研究利用基质条件培养基(CM)保护原代慢性淋巴细胞白血病(CLL)细胞免受自发死亡的观察,发现CCL2是CM依赖细胞存活的关键细胞因子,抗CCL2抗体预处理增强venetoclax杀伤;9/23例样本为CM非依赖(CMI),其中80%携带未突变IGHV,FLT3抑制剂显著降低CMI样本活力。

要点

  • CCL2是基质CM中支持CLL短期存活的主要细胞因子,抗CCL2抗体增强venetoclax杀伤。
  • 9/23例CLL样本为CMI,CMI细胞对凋亡敏感性低于常规基质依赖CLL。
  • CMI样本中80%为未突变IGHV,FLT3抑制剂显著降低其细胞活力。

核心结论

  • 基于CM依赖性可区分两个生物学上不同的CLL亚组,并靶向其不同的微环境脆弱性。

研究设计与样本

  • 利用基质条件培养基(CM)保护原代CLL细胞免受自发死亡的观察,对原代CLL细胞进行短期体外培养及功能研究。
  • 纳入23例CLL样本进行CM依赖性分组,其中9例为CM非依赖(CMI)。

主要发现

  • CM中支持CLL短期体外存活的最主要细胞因子是CCL2。
  • 抗CCL2抗体预处理CLL细胞可增强venetoclax介导的杀伤。
  • 9/23例CLL样本在无CM支持时较不易发生细胞死亡,定义为CMI。
  • CMI CLL细胞对凋亡的敏感性低于常规基质依赖CLL。
  • CMI样本中80%携带未突变IGHV;bulk RNA测序显示黏着斑和RAS信号通路上调,并表达FLT3和CD135。

关键数值与推荐

  • CMI判定:9/23例CLL样本在无CM支持时较不易发生细胞死亡。
  • CMI样本中80%携带未突变IGHV。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The importance of the stromal microenvironment in chronic lymphocytic leukemia (CLL) pathogenesis and drug resistance is well established. Despite recent advances in CLL therapy, identifying novel ways to disrupt interactions between CLL and its microenvironment may identify new combination partners for the drugs currently in use. To understand the role of microenvironmental factors on primary CLL cells, we took advantage of an observation that conditioned media (CM) collected from stroma was protective of CLL cells from spontaneous cell death ex vivo. The cytokine in the CM-dependent cells that most supports CLL survival in short-term ex vivo culture was CCL2. Pretreatment of CLL cells with anti-CCL2 antibody enhanced venetoclax-mediated killing. Surprisingly, we found a group of CLL samples (9/23 cases) that are less likely to undergo cell death in the absence of CM support. Functional studies revealed that CM-independent (CMI) CLL cells are less sensitive to apoptosis than conventional stroma-dependent CLL. In addition, a majority of the CMI CLL samples (80%) harbored unmutated immunoglobulin heavy-chain variable (IGHV) region. Bulk-RNA sequence analysis revealed upregulation of the focal adhesion and RAS signaling pathways in this group, along with expression of fms-like tyrosine kinase 3 (FLT3) and CD135. Treatment with FLT3 inhibitors caused a significant reduction in cell viability among CMI samples. In summary, we were able to discriminate and target 2 biologically distinct subgroups of CLL based on CM dependence with distinct microenvironmental vulnerabilities.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Parvin S, Aryal A, Yin S, et al. Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia. Blood Adv. 2023. PMID: 37428863. doi:10.1182/bloodadvances.2022008207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。